Results 121 to 130 of about 4,177,143 (225)

Effect of Coating Solvent Ratio on the Drug Release Lag Time of Coated Theophylline Osmotic Tablets

, 2009
Mahibub Mahamadsa Kanakal, MHF Sakeena, M. N. Azmin, D Yusrida   +3 more
openalex   +2 more sources

Associations between cerebral blood transit time, amyloid-β pathology and cognitive decline in non-demented older adults. [PDF]

Alzheimers Dement
Zhang Y, Luo X, Hong H, Zhang R, Wang S, Liu L, Lin M, Li K, Zeng Q, Chen Y, Sun J, Huang P.   +11 more
europepmc   +1 more source

Phenotypic and targeted drug discovery in immune therapeutics: challenges, opportunities, and future directions. [PDF]

RSC Adv
Vázquez NG, Nada H, Upadhyay S, Gabr MT.   +3 more
europepmc   +1 more source

CXCR6⁺ T Cells Drive Immune Checkpoint Inhibitor Myocarditis. [PDF]

Circulation
Munir AZ, Gutierrez A, Krawiec CJ, Manandhar P, Shyani AC, Ma P, Gougis P, Baylis RA, Hou L, Remold-O'Donnell E, Balko JM, Salem JE, Lavine KJ, Lichtman AH, Qin J, Moslehi JJ.   +15 more
europepmc   +1 more source

Association between weather, air quality and asthma-related emergency department visits: a retrospective time-series study in Singapore. [PDF]

BMJ Open
Toh MR, Wen X, Ng GXZ, Fun AQR, Youxin P, Fong L, Wu JT, Ong M, Matchar DB, Tan NC, Loo CM, Sheikh A, Koh MS, Lam SW.   +13 more
europepmc   +1 more source

In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time

, 1996
Maria Angela Vandelli, Eliana Leo, Flavio Forni, Bernabei Mt   +3 more
openalex   +1 more source

Drug-Induced Bullous Pemphigoid Triggered by Immune Checkpoint Inhibitor Opdualag in an Elderly Patient With Recurrent Metastatic Melanoma: A Case Report and Treatment Course With Dupilumab. [PDF]

Cureus
Moreno BA, Lutwak M, Lutwak D, Kerdel F.
europepmc   +1 more source

Novel anti-LAG-3 antibody LBL-007 with anti-PD-1 blockade enhances antitumor immunity by promoting T cell-induced apoptosis. [PDF]

Sci Rep
Qin K, Zhou H, Yu X, Liu J, Wu C, Zhang C, Zhou L.   +6 more
europepmc   +1 more source

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial. [PDF]

Nat Med
Long GV, Garnett-Benson C, Dolfi S, Ascierto PA, Guo J, Tarhini AA, Chandra S, Muñoz-Couselo E, Del Vecchio M, de Melo AC, Callahan M, Gogas H, Dummer R, Schadendorf D, Koelblinger P, Quereux G, Thomas I, Yu JX, Fisher A, Wang B, Djidel P, Chouzy A, Semaan M, Chen B, Cheong AMY, Tawbi HA.   +25 more
europepmc   +1 more source

Beyond monotherapy: multimodal strategies integrating immune checkpoint inhibitors in lymphoma management. [PDF]

Front Immunol
Li Y, Zheng R, Pan B, Wang X, Zhang L, Gao H, Li L.   +6 more
europepmc   +1 more source